| __timestamp | ACADIA Pharmaceuticals Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 1271353000 |
| Thursday, January 1, 2015 | 73869000 | 1620577000 |
| Friday, January 1, 2016 | 99284000 | 2052295000 |
| Sunday, January 1, 2017 | 149189000 | 2075142000 |
| Monday, January 1, 2018 | 187163000 | 2186100000 |
| Tuesday, January 1, 2019 | 240385000 | 3036600000 |
| Wednesday, January 1, 2020 | 319130000 | 2735000000 |
| Friday, January 1, 2021 | 239415000 | 2908100000 |
| Saturday, January 1, 2022 | 361575000 | 3592500000 |
| Sunday, January 1, 2023 | 351619000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
In pursuit of knowledge
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Regeneron consistently outpaced ACADIA, with R&D expenses peaking at approximately $4.4 billion in 2023, marking a 250% increase from 2014. In contrast, ACADIA's R&D spending grew by nearly 480% over the same period, reaching around $352 million in 2023. This disparity highlights Regeneron's robust financial capacity and ACADIA's rapid growth trajectory.
These trends underscore the dynamic nature of the biopharmaceutical industry, where strategic R&D investments can drive innovation and market leadership. As these companies continue to evolve, their R&D strategies will remain pivotal in shaping their future success.
Novartis AG or Regeneron Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
R&D Insights: How Sanofi and Regeneron Pharmaceuticals, Inc. Allocate Funds
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending